Pharmacokinetics and pharmacodynamics of the factor Xa inhibitor apixaban after oral and intravenous administration to cats.

Objective: To determine pharmacokinetic and pharmacodynamic properties of the novel factor Xa inhibitor apixaban in clinically normal cats.

Animals: 5 purpose-bred domestic shorthair cats.

Procedures: A single dose of apixaban (0.